Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuen Chan

Showing results (291-300 of 418) with videos related to

Pageof 42
Sort By:
Scientific Reports|March 9, 2021
A prospective 5-year study on the use of transient elastography to monitor the improvement of non-alcoholic fatty liver disease following bariatric surgeryShirley Yuk-Wah Liu, Vincent Wai-Sun Wong, Simon Kin-Hung Wong, et al.
BJU International|February 21, 2014
One-stop clinic for ketamine-associated uropathy: report on service delivery model, patients' characteristics and non-invasive investigations at baseline by a cross-sectional study in a prospective cohort of 318 teenagers and young adultsYuk-Him Tam, Chi-Fai Ng, Kristine Kit-Yi Pang, et al.
Journal of Viral Hepatitis|April 28, 2020
Thiazolidinediones reduce the risk of hepatocellular carcinoma and hepatic events in diabetic patients with chronic hepatitis BTerry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Henry Lik-Yuen Chan, et al.
Alimentary Pharmacology & Therapeutics|September 6, 2025
Comparative Risk of Hepatitis B Virus Reactivation in Patients Receiving Immune Checkpoint Inhibitors or Tyrosine Kinase Inhibitors for Liver CancerDorothy Cheuk-Yan Yiu, Jimmy Che-To Lai, Landon Long Chan, et al.
Hepatology (Baltimore, Md.)|December 23, 2021
Angiotensin-converting enzyme inhibitors prevent liver-related events in nonalcoholic fatty liver diseaseXinrong Zhang, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 5, 2020
Hepatic Decompensation in Cirrhotic Patients Receiving Antiviral Therapy for Chronic Hepatitis BHye Won Lee, Terry Cheuk-Fung Yip, Yee-Kit Tse, et al.
Journal of Gastroenterology and Hepatology|April 29, 2020
Elevated testosterone increases risk of hepatocellular carcinoma in men with chronic hepatitis B and diabetes mellitusTerry Cheuk-Fung Yip, Grace Lai-Hung Wong, Henry Lik-Yuen Chan, et al.
Gut|June 29, 2010
Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 yearsVincent Wai-Sun Wong, Grace Lai-Hung Wong, Paul Cheung-Lung Choi, et al.
International Journal of Cancer|March 10, 2009
High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis BVincent Wai-Sun Wong, Jun Yu, Alfred Sze-Lok Cheng, et al.
The American Journal of Gastroenterology|February 9, 2021
Hepatitis Flare During Immunotherapy in Patients With Current or Past Hepatitis B Virus InfectionGrace Lai-Hung Wong, Vincent Wai-Sun Wong, Vicki Wing-Ki Hui, et al.
Pageof 42

Showing results (291-300 of 418) with videos related to

Sort By:
Pageof 42
Scientific Reports|March 9, 2021
A prospective 5-year study on the use of transient elastography to monitor the improvement of non-alcoholic fatty liver disease following bariatric surgeryShirley Yuk-Wah Liu, Vincent Wai-Sun Wong, Simon Kin-Hung Wong, et al.
BJU International|February 21, 2014
One-stop clinic for ketamine-associated uropathy: report on service delivery model, patients' characteristics and non-invasive investigations at baseline by a cross-sectional study in a prospective cohort of 318 teenagers and young adultsYuk-Him Tam, Chi-Fai Ng, Kristine Kit-Yi Pang, et al.
Journal of Viral Hepatitis|April 28, 2020
Thiazolidinediones reduce the risk of hepatocellular carcinoma and hepatic events in diabetic patients with chronic hepatitis BTerry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Henry Lik-Yuen Chan, et al.
Alimentary Pharmacology & Therapeutics|September 6, 2025
Comparative Risk of Hepatitis B Virus Reactivation in Patients Receiving Immune Checkpoint Inhibitors or Tyrosine Kinase Inhibitors for Liver CancerDorothy Cheuk-Yan Yiu, Jimmy Che-To Lai, Landon Long Chan, et al.
Hepatology (Baltimore, Md.)|December 23, 2021
Angiotensin-converting enzyme inhibitors prevent liver-related events in nonalcoholic fatty liver diseaseXinrong Zhang, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 5, 2020
Hepatic Decompensation in Cirrhotic Patients Receiving Antiviral Therapy for Chronic Hepatitis BHye Won Lee, Terry Cheuk-Fung Yip, Yee-Kit Tse, et al.
Journal of Gastroenterology and Hepatology|April 29, 2020
Elevated testosterone increases risk of hepatocellular carcinoma in men with chronic hepatitis B and diabetes mellitusTerry Cheuk-Fung Yip, Grace Lai-Hung Wong, Henry Lik-Yuen Chan, et al.
Gut|June 29, 2010
Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 yearsVincent Wai-Sun Wong, Grace Lai-Hung Wong, Paul Cheung-Lung Choi, et al.
International Journal of Cancer|March 10, 2009
High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis BVincent Wai-Sun Wong, Jun Yu, Alfred Sze-Lok Cheng, et al.
The American Journal of Gastroenterology|February 9, 2021
Hepatitis Flare During Immunotherapy in Patients With Current or Past Hepatitis B Virus InfectionGrace Lai-Hung Wong, Vincent Wai-Sun Wong, Vicki Wing-Ki Hui, et al.
Pageof 42